Enbrel denied by insurance? Appeal and win.
A denial of Enbrel is the start of a process, not the end of it. Enbrel is a specialty biologic, so plans almost always gate it behind prior authorization, step therapy, and tight medical-necessity criteria, and most denials come down to documentation that was missing rather than a patient who does not qualify. These denials are frequently overturned when the appeal maps your diagnosis and prior therapy history directly to the plan's own coverage rules.
Reviewed by the Apellica Appeals Team · Updated June 2026
Carrier names and logos are trademarks of their respective owners. Apellica is independent and not affiliated with any insurance carrier or carrier's appeal program.
Enbrel (etanercept) is FDA approved to reduce signs and symptoms in several inflammatory conditions. In adults, it is indicated for moderately to severely active rheumatoid arthritis, active psoriatic arthritis, and active ankylosing spondylitis, and for chronic moderate to severe plaque psoriasis in patients who are candidates for systemic therapy or phototherapy. It is also approved for moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years and older, and for chronic moderate to severe plaque psoriasis in patients 4 years and older. In rheumatoid and psoriatic arthritis it can also slow the progression of joint damage and improve physical function.
Why Enbrel gets denied
- Step therapy not satisfied: the plan requires documented trial and failure of conventional DMARDs such as methotrexate, sulfasalazine, or leflunomide at an adequate dose and duration before approving a biologic.
- Preferred-product requirement: many plans now designate a different TNF inhibitor or an etanercept biosimilar as the preferred agent and deny brand Enbrel until the preferred option is tried or shown to be inappropriate.
- Prior authorization criteria not documented: the request is missing required elements such as the specialist diagnosis, disease severity, or a negative tuberculosis and hepatitis B screening within the plan's lookback window.
- Non-formulary or tier placement: Enbrel is excluded from the formulary or placed on a high specialty tier, so the plan denies coverage absent a formulary or tier exception.
What a winning appeal includes
- A clear diagnosis with the correct ICD-10 code (for example M05/M06 for rheumatoid arthritis, L40.x for psoriasis, M45 for ankylosing spondylitis, or L40.5 for psoriatic arthritis) confirmed by the prescribing specialist.
- A documented history of prior therapies tried and failed, with drug names, doses, dates, and the reason each was stopped, including any contraindication or intolerance to required step-therapy agents or the preferred biosimilar.
- A letter of medical necessity that maps each of the plan's published prior authorization criteria to the specific facts in the chart, point by point.
- Current clinical and safety documentation specific to Enbrel, including disease activity measures and a negative TB and hepatitis B screening within the plan's required timeframe.
How we approach the appeal
Start by identifying which type of denial you received, because the path differs. If the drug is non-formulary or on a high tier, file a formulary or tier exception; if it is a prior authorization or step-therapy denial, file a medical-necessity appeal that quotes the plan's own criteria language back to it and attaches the documentation each criterion requires. Pull the plan's published coverage policy for etanercept, address every listed requirement in order, and where step therapy applies, either show the required agents were tried and failed or invoke a documented contraindication or intolerance, including for any preferred biosimilar. If the internal appeal is upheld, request an external review through your state's independent review process within the stated deadline.
Enbrel appeal letter template
Copy this Enbrel appeal letter, fill in the brackets, and send it within your deadline. It is built on what overturns TNF inhibitor denials.
[Date] [Your name] · Member ID [ID] · Rx claim # [#] [Insurer or PBM] - Appeals Department Re: Appeal of Enbrel denial I am appealing the denial of Enbrel (etanercept). I request that the denial be overturned and Enbrel approved. 1. The denial. [Insurer] denied Enbrel stating, verbatim: "[paste the exact denial reason from your letter]." 2. Medical necessity. Enbrel is medically necessary for my condition. Start by identifying which type of denial you received, because the path differs. If the drug is non-formulary or on a high tier, file a formulary or tier exception; if it is a prior authorization or step-therapy denial, file a medical-necessity appeal that quotes the plan's own criteria language back to it and attaches the documentation each criterion requires. Pull the plan's published coverage policy for etanercept, address every listed requirement in order, and where step therapy applies, either show the required agents were tried and failed or invoke a documented contraindication or intolerance, including for any preferred biosimilar. If the internal appeal is upheld, request an external review through your state's independent review process within the stated deadline. 3. Step-therapy or formulary exception (if that was the reason): I have tried and failed [preferred drug(s)], with pharmacy records attached, or the preferred alternative is contraindicated because [reason]. I request a formulary or step-therapy exception. 4. My request. Approve Enbrel within the timeframe required by law. If the denial is upheld, please provide the specific criteria used, the reviewing clinician's credentials, and external-review instructions. Attached: prescriber letter of medical necessity, pharmacy and prior-trial records, and supporting clinical notes. Sincerely, [Your name]
Want it built and filed for you? Use the free generator, or have Apellica do it.
Internal appeals: 30 days pre-service, 60 days post-service, 72 hours urgent. File within 180 days of the denial.
$0 upfront. We assess fit first, then build and file the appeal for you.
- · The denial letter and your Explanation of Benefits (EOB)
- · Insurance ID, plan name, and the claim or prior-authorization number
- · Diagnosis with ICD-10 code and the prescriber's clinical notes
- · A record of treatments already tried and how they worked
Appealing a Enbrel denial by insurer
The path depends on who manages your benefit. The most common:
Coverage runs through the pharmacy benefit. Appeal the coverage determination and, when the drug is non-formulary, file a formulary or tier exception with a provider attestation that covered alternatives are unsuitable.
Publishes detailed prior-authorization criteria. A denial usually means a criterion was not documented. Appeal through a coverage review, with a formulary exception for excluded drugs.
Administers many UnitedHealthcare and employer plans. Appeals and exceptions follow the plan's published PA criteria; expedited review exists for urgent cases.
Internal appeal first, then independent external review. Pre-service decisions are generally made within 30 days, urgent within 72 hours.
Internal appeals and external review; pharmacy denials often route through OptumRx criteria.
Independent state plans, so criteria vary. Match the appeal to your specific BCBS plan, internal appeal first, then external review.
Frequently asked questions
My plan says I have to try a biosimilar or a different TNF inhibitor before Enbrel. Can I still appeal?
Yes. Step-therapy and preferred-product requirements can be appealed. The strongest appeals either document that the required agents were already tried and did not work or were not tolerated, or establish a medical reason the preferred agent is inappropriate for you. If you previously did well on Enbrel, a recent paid claim or pharmacy record showing prior stable use can support a request to stay on it rather than switch.
Why does the insurer want my TB and hepatitis B test results?
Enbrel carries a boxed warning for serious infections, including reactivation of tuberculosis and hepatitis B. Most plans require a negative or appropriately managed screening within a set lookback period, often the past 12 months, as a condition of coverage. Including these results up front removes one of the most common reasons a prior authorization is delayed or denied.
Is Enbrel covered under my medical benefit or my pharmacy benefit?
Enbrel is a self-administered subcutaneous injection, so it is almost always covered under the pharmacy (drug) benefit and dispensed through a specialty pharmacy, not infused in a clinic. That means appeals run through the pharmacy benefit and its prior authorization and exception process rather than a medical site-of-care review, which is worth confirming so your appeal is filed with the correct department and deadline.
Enbrel denied? We fight it for you.
$0 upfront. Two-minute intake. We confirm fit and reply within one business day with the right path for your situation.
Start Your AppealThis page provides general information about appeal strategy. It is not legal or medical advice. Apellica is not a law firm. Outcomes depend on documentation, plan terms, and timing.